Chargement en cours...
Buprenorphine and Opioid Antagonism, Tolerance, and Naltrexone-Precipitated Withdrawal
The dual antagonist effects of the mixed-action μ-opioid partial agonist/κ-opioid antagonist buprenorphine have not been previously compared in behavioral studies, and it is unknown whether they are comparably modified by chronic exposure. To address this question, the dose-related effects of levorp...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The American Society for Pharmacology and Experimental Therapeutics
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3033719/ https://ncbi.nlm.nih.gov/pubmed/21051498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.110.173823 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|